There’s a type of investor nobody talks about much. They’re not buying and selling every week. They’re not glued to financial news. They bought a handful of stocks years ago, reinvested the dividends, and let time do the heavy lifting. Most of them have quietly done better than the traders.
I’ve been at this for over 40 years. The best thing I ever learned was that companies raising their dividends for decades don’t do it by accident. It takes a durable business, disciplined management, and a competitive position that doesn’t crumble when the economy turns. Those companies are rare. When you find them, you hold them.
Below are three names I’d own without hesitation if I were starting fresh today. Each one has a track record that speaks for itself.
Coca-Cola (KO)
Coca-Cola has raised its dividend for 63 consecutive years. That streak runs through recessions, wars, inflation spikes, tech bubbles, and a global pandemic. The company’s payout has survived things that wiped out entire industries.
Here’s what makes 2026 interesting: Coke is outperforming every Magnificent Seven stock year to date. While AI names got volatile, Coke delivered Q1 results showing a 12% jump in net revenue and a 3% increase in unit case volumes — meaning consumers are still buying more even with higher prices. That’s harder than it sounds. Pricing power and demand growth at the same time is genuinely rare.
The stock trades near $78 with a yield around 2.6%. Not flashy. But you’re buying a brand that earns pricing power year after year, and a dividend that’s been growing longer than most investors have been alive.
Johnson & Johnson (JNJ)
If Coca-Cola defines consumer durability, Johnson & Johnson defines healthcare durability. The company just raised its quarterly dividend to $1.34 per share, or $5.36 annualized, extending a streak of consecutive annual increases past 62 years. That makes it a Dividend King — a company that has raised its payout every single year for at least half a century.
The underlying business is genuinely strong. J&J has guided for $11.45 to $11.65 in earnings per share for 2026, with both its pharmaceutical and medtech segments growing. Market cap sits north of $546 billion. These aren’t the numbers of a company running on fumes.
At around $227 with a yield near 2.4%, this isn’t a high-yield play. What you’re buying is consistency. The kind of company that will still be writing checks in 2046 regardless of what the market throws at it.
Realty Income (O)
Most dividend stocks pay quarterly. Realty Income pays monthly. If you’re living on dividend income — or reinvesting it — that monthly cadence makes a real difference in how your money compounds over time.
Realty Income owns more than 15,400 properties across the U.S. and Europe. Drugstores, grocery-anchored retail, industrial facilities. Tenants sign long-term leases, and the income flows almost like clockwork. The company has increased its dividend 133 times since going public in 1994, including 31 consecutive years of annual increases. It earns its spot on the S&P 500 Dividend Aristocrats index.
The stock trades around $64 with a yield just over 5%. That’s real income. The company is guiding for $4.38 to $4.42 in AFFO per share for 2026 — AFFO, or adjusted funds from operations, is the standard way to measure a REIT’s earning power, similar to earnings per share for a regular company. Shares are up more than 11% so far this year, but the yield still looks attractive.
These aren’t exciting stocks. But that’s the point. The boring ones are usually the ones still standing 20 years from now.
